AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

8,277.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 8,812.00p
  • 52 Week Low: 6,794.00p
  • Currency: UK Pounds
  • Shares Issued: 1,549.12m
  • Volume: 2,399,016
  • Market Cap: £128,220m
  • RiskGrade: 123

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.
Registrars: Equiniti
Brands: Losec, Prilosec, Nexium, Crestor

Key Personnel

Senior Independent Non-Executive Director: Philip A J Broadley
CEO and Executive director: Pascal Soriot
CFO & Executive Director: Marc Dunoyer
Non-Executive Chairman: Leif Johansson
Non-Executive Dir: Michel Demare, Sheri McCoy, Marcus Wallenberg, Euan Ashley, Deborah DiSanzo, Diana Layfield , Tony Mok, Nazneen Rahman

Contact Details

Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge,United Kingdom, CB2 0AA
Phone: +44 (0)20 3749 5000
Fax: +44 (0)20 7604 8151
Website: http://www.astrazeneca.com

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARKFTSE 100FTSEurofirst 300FTSE 350FTSE All-Share
Overseas Listings: BATSLON:AZNL, NYSE:AZN
ISIN: GB0009895292

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 8,277.00p
Change Today 11.00p
% Change 0.13 %
52 Week High 8,812.00p
52 Week Low 6,794.00p
Volume 2,399,016
Shares Issued 1,549.12m
Market Cap £128,220m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.42% below the market average84.42% below the market average84.42% below the market average84.42% below the market average84.42% below the market average
1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average
Price Trend
14.9% below the market average14.9% below the market average14.9% below the market average14.9% below the market average14.9% below the market average
4.92% above the sector average4.92% above the sector average4.92% above the sector average4.92% above the sector average4.92% above the sector average
Income
31.42% below the market average31.42% below the market average31.42% below the market average31.42% below the market average31.42% below the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
88.35% above the market average88.35% above the market average88.35% above the market average88.35% above the market average88.35% above the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average

What The Brokers Say

Strong Buy 21
Buy 2
Neutral 3
Sell 0
Strong Sell 1
Total 27
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 12-Aug-21 25-Feb-21
Paid 13-Sep-21 29-Mar-21
Amount 90.00¢ 190.00¢

Trades for 29-Jul-2021

Time Volume / Share Price
16:36 21 @ 8,277.00p
16:36 1,000 @ 8,277.00p
16:36 300 @ 8,277.00p
16:36 100 @ 8,277.00p
16:35 918,420 @ 8,277.00p

Top of Page